Catherine Wölfel

3.3k citations
24 papers · 2.6k · 2 hit papers · h-index 17

Impact in

  • Immunology top 1%
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • Immune Cell Function and Interaction
  • Oncology top 2%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
    • Cancer-related Molecular Pathways

Papers in

    • T-cell and B-cell Immunology 11
    • Immunotherapy and Immune Responses 9
    • Immune Cell Function and Interaction 7
    • Biosimilars and Bioanalytical Methods 2
    • CAR-T cell therapy research 7
    • Cancer Immunotherapy and Biomarkers 2

Catherine Wölfel

23 papers receiving 2.5k citations

Hit Papers

A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma 1995 · 900 citations
9000+11+22Years since publication250500750

Peers

Catherine Wölfel
Comparison fields: 5 of 88
  • Immunology 1.7k
  • Oncology 1.3k
  • Pharmacology 175
  • Molecular Biology 1.1k
  • Cancer Research 242
Replace Geeta Devgan with:
Geeta Devgan United States
Chao‐Lan Yu United States
Leonie A. Cluse Australia
Marc M. Oshiro United States
Robyn Catlett-Falcone United States
Ming‐Hai Wang United States
Donna Headlee United States
Sajjad A. Qureshi United States
David A. Proia United States
Michael J. Campbell United States
Catherine Wölfel relative to Geeta Devgan United States Geeta Devgan's profile →
Citations per field
00.5×1.5×1.9×
Geeta Devgan · 1×
Citations per year

Countries citing papers authored by Catherine Wölfel

Since Specialization
Citations

This map shows the geographic impact of Catherine Wölfel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Wölfel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Wölfel more than expected).

Fields of papers citing papers by Catherine Wölfel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Wölfel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Wölfel. The network helps show where Catherine Wölfel may publish in the future.

Co-authors

The 25 scholars most cited alongside Catherine Wölfel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Catherine Wölfel Line = papers co-authored together Catherine Wölfel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Hit paper breakdown →
1995900
2
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
Hit paper breakdown →
1993785
3 2005348
4 1992131
5 199453
6 199152
7 200045
8 199240
9 200430
10 201329
11 199129
12 200728
13 201725
14 199321
15 200821
16 199221
17 200816
18 200711
19 19956
20 20204

About Catherine Wölfel

Catherine Wölfel is a scholar working on Immunology, Oncology, Molecular Biology, Pharmacology and Cancer Research, having authored 24 papers that have together received 2.6k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (11 papers), Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Carcinogens and Genotoxicity Assessment (4 papers), Biosimilars and Bioanalytical Methods (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Immunology (1.7k citations), Oncology (1.3k citations), Pharmacology (175 citations), Molecular Biology (1.1k citations) and Cancer Research (242 citations). Catherine Wölfel has collaborated with scholars based in Germany, Switzerland and Belgium. Frequent co-authors include Thomas Wölfel, Etienne De Plaen, Aline Van Pel, Vincent Brichard, Pierre G. Coulie, Thierry Boon, Bernard Lethé, Karl‐Hermann Meyer zum Büschenfelde, Thomas Hankeln and Jörg Schneider. Their work appears in journals such as International Journal of Cancer, Frontiers in Immunology, Blood, Molecular Carcinogenesis and Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact